ANEST IWATA (6381) Q2 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2027 earnings summary
10 Nov, 2026Executive summary
H1 FY2026 net sales rose 19.6% YoY to ¥31,478 million; operating profit increased 44.3% to ¥3,623 million, ordinary profit 28.7% to ¥4,241 million and parent-attributable profit 22.5% to ¥2,647 million.
Growth reflected stronger demand across air compressors and coating businesses, regional sales gains and SANWA consolidation; full-year forecasts remained unchanged.
Financial highlights
Results exceeded the August 10 first-half forecast: net sales by 3.2%, operating profit by 20.8%, ordinary profit by 11.6% and net income by 15.1%.
Gross profit was ¥14,400 million versus ¥12,228 million YoY; SG&A was ¥10,776 million versus ¥9,716 million.
Comprehensive income was ¥4,320 million, up 182.3% YoY, including ¥1,163 million of other comprehensive income.
FX impact: net sales +¥1,886 million and operating profit +¥103 million; ordinary profit -¥120 million and profit -¥107 million.
Outlook and guidance
FY2026 forecast unchanged: net sales ¥60,700 million, operating profit ¥5,400 million, ordinary profit ¥6,460 million and parent-attributable profit ¥3,950 million; EPS ¥100.45.
FY2026 annual dividend forecast is ¥93/share, including ¥5/share in commemorative dividends; interim dividend was ¥43 and year-end forecast is ¥50.
A new oil-free medium-sized air compressor is scheduled to launch in FY2026, with earnings contribution expected from the next fiscal year; forecast assumptions exclude potential component-cost increases and longer lead times.
Latest events from ANEST IWATA
- Strong sales and profit growth driven by compressors, coating, and SANWA acquisition.6381
Q1 2027 - Aims for ¥100B sales by 2035 via global expansion, innovation, and new business creation.6381
Investor presentation - Sales rose 2.8% and profit surged 25.2%, with a compressor business acquisition planned.6381
Q4 2026 - Profits and sales fell, but financial stability and full-year guidance were maintained.6381
Q3 2026 - Sales and profit fell, but FX gains and cash flow stability kept guidance unchanged.6381
Q2 2026 - Q1 sales and profits declined, comprehensive income turned negative, but guidance is unchanged.6381
Q1 2026 - Sales rose but profits fell on margin and forex pressures; outlook and dividend steady.6381
Q2 2025 - Sales rose but profits fell on higher costs; full-year outlook maintained amid global risks.6381
Q1 2025 - Sales up, profits down; FY2025 targets higher sales, lower earnings, and a dividend increase.6381
Q4 2025